| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| BOUSBIB ARI | Chairman, Chief Executive Officer & President, Director | C/O IQVIA HOLDINGS INC., 2400 ELLIS ROAD, DURHAM | /s/ Matthew Gilmartin, Attorney-in-Fact for Ari Bousbib | 31 Oct 2025 | 0001184180 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Common Stock | Options Exercise | $4,647,761 | +77,592 | +9.6% | $59.90 | 884,755 | 29 Oct 2025 | Direct | F1 |
| transaction | IQV | Common Stock | Sale | $174,064 | -800 | -0.09% | $217.58 | 883,955 | 29 Oct 2025 | Direct | F1, F2 |
| transaction | IQV | Common Stock | Sale | $1,597,011 | -7,315 | -0.83% | $218.32 | 876,640 | 29 Oct 2025 | Direct | F1, F3 |
| transaction | IQV | Common Stock | Sale | $3,013,264 | -13,741 | -1.6% | $219.29 | 862,899 | 29 Oct 2025 | Direct | F1, F4 |
| transaction | IQV | Common Stock | Sale | $1,012,506 | -4,600 | -0.53% | $220.11 | 858,299 | 29 Oct 2025 | Direct | F1, F5 |
| transaction | IQV | Common Stock | Sale | $5,782,388 | -26,128 | -3% | $221.31 | 832,171 | 29 Oct 2025 | Direct | F1, F6 |
| transaction | IQV | Common Stock | Sale | $881,887 | -3,973 | -0.48% | $221.97 | 828,198 | 29 Oct 2025 | Direct | F1, F7 |
| transaction | IQV | Common Stock | Disposed to Issuer | $4,647,894 | -21,035 | -2.5% | $220.96 | 807,163 | 29 Oct 2025 | Direct | F1 |
| holding | IQV | Common Stock | 543,302 | 29 Oct 2025 | By Trust | F8 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IQV | Stock Appreciation Right | Options Exercise | $4,647,761 | -77,592 | -61% | $59.90 | 50,000 | 29 Oct 2025 | Common Stock | 77,592 | $59.90 | Direct |
| Id | Content |
|---|---|
| F1 | Represents the exercise of stock appreciation rights expiring on February 2, 2026. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $216.70 to $217.70, inclusive. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $217.73 to $218.70, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $218.73 to $219.66, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $219.74 to $220.62, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.77 to $221.72, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $221.82 to $222.27, inclusive. |
| F8 | Shares held in Orohena Trust. |
Chairman, Chief Executive Officer & President